Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hemogenyx Pharmaceuticals Plc. (HOPHF)

Hemogenyx Pharmaceuticals Plc. (HOPHF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Most Recent Stories

More News
Hemogenyx Pharmaceuticals PLC Announces Second Patient Treated with HG-CT-1 CAR-T Therapy

LONDON, GB / ACCESS Newswire / May 2, 2025 / Hemogenyx Pharmaceuticals plc (LSE: HEMO) is pleased to announce that the second patient has been successfully treated as part of the Company's ongoing Phase...

HEMO.LN : 970.000 (-4.43%)
HOPHF : 2.3300 (unch)
Hemogenyx Pharmaceuticals PLC Announces Final Results

LONDON, UNITED KINGDOM / ACCESS Newswire / April 28, 2025 / Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces...

HEMO.LN : 970.000 (-4.43%)
HOPHF : 2.3300 (unch)
Hemogenyx Pharmaceuticals PLC Announces FDA Annual Report

Hemogenyx Pharmaceuticals Files Annual IND Report with FDA for HG-CT-1 CAR-T Therapy for AML

HEMO.LN : 970.000 (-4.43%)
HOPHF : 2.3300 (unch)
Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights

LONDON, GB / ACCESS Newswire / March 31, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces that the total...

HEMO.LN : 970.000 (-4.43%)
HOPHF : 2.3300 (unch)
Hemogenyx Pharmaceuticals PLC Announces First Patient Safety

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU WHICH IS PART OF DOMESTIC UK LAW PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIIONS (SI...

HEMO.LN : 970.000 (-4.43%)
HOPHF : 2.3300 (unch)
Hemogenyx Pharmaceuticals PLC Announces Recruitment of Second Patient for Clinical Trials

Recruitment of Second Patient for HG-CT-1 Clinical Trial

HEMO.LN : 970.000 (-4.43%)
HOPHF : 2.3300 (unch)
Hemogenyx Pharmaceuticals PLC Announces Institutional Investment

Institutional backing of £709,200 for continuing Phase 1 Clinical Trials

HEMO.LN : 970.000 (-4.43%)
HOPHF : 2.3300 (unch)
Hemogenyx Pharmaceuticals PLC Announces First-in-Human Treatment with HG-CT-1

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU WHICH IS PART OF DOMESTIC UK LAW PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS (SI...

HEMO.LN : 970.000 (-4.43%)
HOPHF : 2.3300 (unch)
Hemogenyx Pharmaceuticals PLC Announces Issue of Convertible Loan Notes

LONDON, UK / ACCESS Newswire / February 19, 2025 / NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN,...

HEMO.LN : 970.000 (-4.43%)
HOPHF : 2.3300 (unch)
Hemogenyx Pharmaceuticals PLC Announces Opening of First Clinical Site

Hemogenyx Pharmaceuticals Opens First Clinical Site for HG-CT-1 Phase I Trial

HEMO.LN : 970.000 (-4.43%)
HOPHF : 2.3300 (unch)

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point N/A
1st Resistance Point N/A
Last Price 2.3300
1st Support Level N/A
2nd Support Level N/A
3rd Support Level N/A

See More

52-Week High 2.3300
Fibonacci 61.8% 2.3300
Fibonacci 50% 2.3300
Fibonacci 38.2% 2.3300
Last Price 2.3300
52-Week Low 2.3300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar